SCHEMBL6614129

SCHEMBL6614129

O=c1cc(-c2ccc(O)cc2O)oc2c(O)c(O)ccc12

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 5/20 0.74
▸ CYP3A4 P08684 5/20 0.74
▸ KDM4E B2RXH2 4/20 0.74
▸ ALOX15 P16050 4/20 0.74
▸ CYP2C19 P33261 4/20 0.74
▸ MEN1 O00255 4/20 0.74
▸ KMT2A Q03164 4/20 0.74
▸ ALDH1A1 P00352 3/20 0.74
▸ MAPT P10636 3/20 0.74
▸ HSD17B10 Q99714 3/20 0.74
▸ CYP2C9 P11712 3/20 0.74
▸ RECQL P46063 2/20 0.74
▸ CYP2D6 P10635 1/20 0.74
▸ TDP1 Q9NUW8 1/20 0.74
▸ TERT O14746 11/20 0.71
▸ TP53 P04637 3/20 0.66
▸ MAPK1 P28482 2/20 0.66
▸ SMN1; SMN2 Q16637 2/20 0.62
▸ BRD4 O60885 1/20 0.62
▸ IKBKB O14920 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6803555 0.88 CYP3A4 (0.73) HPGDCYP3A4KDM4EALOX15CYP2C19
SCHEMBL4625656 0.85 CYP3A4 (1.00) HPGDCYP3A4KDM4EALOX15CYP2C19
SCHEMBL4649959 0.83 TERT (1.00) HPGDCYP3A4KDM4EALOX15CYP2C19
SCHEMBL31322174 0.83 TERT (1.00) HPGDCYP3A4KDM4EALOX15CYP2C19
SCHEMBL6803326 0.82 CYP3A4 (0.83) HPGDCYP3A4KDM4EALOX15CYP2C19
SCHEMBL6832163 0.80 HPGD (0.80) HPGDCYP3A4KDM4EALOX15CYP2C19
SCHEMBL4649946 0.79 TERT (1.00) HPGDCYP3A4KDM4EALOX15CYP2C19
SCHEMBL6804531 0.78 TERT (0.81) HPGDCYP3A4KDM4EALOX15CYP2C19
SCHEMBL6612819 0.78 HPGD (0.68) HPGDCYP3A4KDM4EALOX15CYP2C19
SCHEMBL35318 0.77 TERT (1.00) HPGDCYP3A4KDM4EALOX15CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040063665-A1 Substituted benzopyranones as telomerase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2004-04-01 — — US claimed
EP-1373244-A2 SUBSTITUTED BENZOPYRANONES AS TELOMERASE INHIBITORS Pharmacia Italia S.p.A. (IT) 2004-01-02 — — EP claimed
US-20020160983-A1 Substituted benzopyranones as telomerase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2002-10-31 — — US claimed
WO-2002074036-A2 SUBSTITUTED BENZOPYRANONES AS TELOMERASE INHIBITORS PHARMACIA ITALIA SPA (IT) 2002-09-26 — — WO claimed
US-20040063665-A1 Substituted benzopyranones as telomerase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2004-04-01 — — US disclosed
EP-1373244-A2 SUBSTITUTED BENZOPYRANONES AS TELOMERASE INHIBITORS Pharmacia Italia S.p.A. (IT) 2004-01-02 — — EP disclosed
US-20020160983-A1 Substituted benzopyranones as telomerase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2002-10-31 — — US disclosed
WO-2002074036-A2 SUBSTITUTED BENZOPYRANONES AS TELOMERASE INHIBITORS PHARMACIA ITALIA SPA (IT) 2002-09-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020160983-A1 Substituted benzopyranones as telomerase inhibitors TERT, TERF2, TERF2IP HPGD 1090/4885CYP3A4 3385/4885KDM4E 908/4885
US-20040063665-A1 Substituted benzopyranones as telomerase inhibitors TERT, TERF2, TERF2IP HPGD 1077/4885CYP3A4 3411/4885KDM4E 889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback